Detection and Management of Acute Kidney Injury (AKI) in Low and Low Middle Income Countries: A Pilot Feasibility Project
NCT ID: NCT02912611
Last Updated: 2020-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2101 participants
INTERVENTIONAL
2016-10-01
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Each site comprises a cluster (including 3-4 health centers - 1 district hospital - 1 regional referral hospital) that service the population around the site area. Patients presenting at a health care clinic or hospital emergency department with signs and symptoms associated with high and moderate risk of developing AKI will undergo a point of care (POC) test to measure serum creatinine, saliva urea nitrogen dipstick (exclusively in Malawi), and a urine dipstick test for color, protein, glucose, blood and specific gravity. Patients who meet the study inclusion criteria will be approached for consent. Patients enrolled in the study will be followed throughout the health care evaluation and tracked through their course by location i.e. health care center, hospital, and home. Outcomes will be recorded through 6 months following the health care evaluation.
The protocol will have an initial observation phase, during which relevant healthcare staff and the research team will be trained to identify patients at moderate or high risk of AKI and use of the point of care (POC) test for serum creatinine, saliva urea nitrogen dipstick (exclusively in Malawi), and urine dipstick test. During this phase patients will be tracked throughout the health care evaluation, however the teleconsultation will not be implemented and no specific guidance for managing the patient will be provided.
During the subsequent intervention phase, the research team will interact with the local healthcare providers to and the teleconsultation physician, providing guidance on the management of the patient based on a standardized protocol. Protocols for patient care will be pre-specified, with minor adjustments to meet local requirements.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutritional Therapy to Prevent Progression of Acute Kidney Injury to Chronic Kidney Disease
NCT02831062
Early Prediction of Acute Kidney Injury in High Risk Patients After Non-cardiac Surgery
NCT03880110
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2
NCT07106151
Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research
NCT02660931
Electronic Warning Systems in Diagnosis and Treatment of AKI
NCT03119480
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moderate and High risk for AKI
Education and Protocol based management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education and Protocol based management
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hypotension/ shock
* Coma
* Jaundice
* Confusion
* Dyspnea
* Symptoms of respiratory infection
* Petechia, ecchymosis, bleeding
* Hypertension (in pregnancy)
Exclusion Criteria
* Kidney transplant patients
* Unable to give informed consent
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Society of Nephrology
OTHER
University of California, San Diego
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ravindra Mehta
Professor of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Obrero #2
Cochabamba, , Bolivia
Queen Elizabeth Central Hospital (QECH)
Blantyre, , Malawi
BP Koirala Institute of Health Sciences
Dharān, Sansari District, Nepal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
160610
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.